CG MedTech Co.,Ltd. (KOSDAQ:056090)

CG MedTech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	24,387	26,939	12,648	22,499	12,336	5,091
Short-Term Investments	1,499	5,841	94.04	40,006	2,689	4,749
Trading Asset Securities	-	1,519	1,605	12,482	5,161	-
Cash & Short-Term Investments	25,886	34,299	14,348	74,987	20,187	9,840
Cash Growth	4.55%	139.05%	-80.87%	271.46%	105.15%	65.91%
Accounts Receivable	5,636	5,435	6,517	7,457	6,768	6,532
Other Receivables	395.86	300.71	336.98	391.72	154.59	56.74
Receivables	6,032	6,532	7,032	8,230	8,841	7,193
Inventory	13,849	12,270	11,515	10,617	10,245	9,198
Prepaid Expenses	165.53	165.95	243.37	68.97	28.31	53.24
Other Current Assets	1,110	813.14	417.09	918.37	392.68	1,758
Total Current Assets	47,042	54,079	33,556	94,821	39,694	28,043
Property, Plant & Equipment	38,173	32,695	29,996	28,270	18,020	17,743
Long-Term Investments	455.34	433.2	508.26	2,940	2,734	2,305
Goodwill	-	1,524	-	-	-	-
Other Intangible Assets	8,371	3,027	1,258	1,458	1,642	1,447
Long-Term Deferred Tax Assets	76.63	16.51	133.72	107.11	59.35	-
Long-Term Deferred Charges	-	124.5	160.5	132.61	262.34	465
Other Long-Term Assets	15,135	14,767	12,214	12,446	12,390	12,413
Total Assets	110,572	107,200	79,098	141,439	75,062	64,432
Accounts Payable	1,784	2,455	1,484	1,221	2,713	1,220
Accrued Expenses	550.1	535.4	431.32	588.42	613.34	946.78
Short-Term Debt	1,392	1,863	3,243	64,918	14,208	8,010
Current Portion of Long-Term Debt	82.07	99.67	0	0	0	10,670
Current Portion of Leases	656.14	346.3	478.88	360.71	275.24	131.01
Current Income Taxes Payable	155.38	13.41	-	13.12	62.1	-
Other Current Liabilities	8,541	6,554	3,100	5,589	4,389	3,154
Total Current Liabilities	13,161	11,867	8,737	72,690	22,261	24,132
Long-Term Debt	1,808	1,448	-	-	15,158	5,000
Long-Term Leases	1,011	674.19	644.81	730.88	333.71	53.34
Long-Term Deferred Tax Liabilities	4,860	4,879	3,721	3,423	25.69	33.68
Other Long-Term Liabilities	931.94	1,155	5,553	6,258	5,962	5,212
Total Liabilities	22,261	20,434	19,198	83,760	46,284	37,347
Common Stock	51,630	51,630	39,440	39,440	4,660	4,073
Additional Paid-In Capital	79,193	79,736	68,260	68,260	65,431	59,414
Retained Earnings	-55,515	-57,197	-57,127	-58,332	-39,532	-34,430
Treasury Stock	-	-	-	-	-1,983	-1,983
Comprehensive Income & Other	12,859	12,997	9,617	8,337	-31.47	11.45
Total Common Equity	88,166	87,165	60,189	57,705	28,544	27,085
Minority Interest	144.58	-398.93	-289.72	-25.91	233.38	-
Shareholders' Equity	88,311	86,766	59,900	57,679	28,778	27,085
Total Liabilities & Equity	110,572	107,200	79,098	141,439	75,062	64,432
Total Debt	4,949	4,431	4,367	66,009	29,975	23,864
Net Cash (Debt)	20,937	29,867	9,981	8,977	-9,788	-14,024
Net Cash Growth	-4.13%	199.24%	11.18%	-	-	-
Net Cash Per Share	197.59	318.28	126.54	134.93	-219.88	-365.46
Filing Date Shares Outstanding	103.26	103.26	78.88	78.88	46.05	40.18
Total Common Shares Outstanding	103.26	103.26	78.88	78.88	46.05	40.18
Working Capital	33,881	42,212	24,819	22,131	17,433	3,912
Book Value Per Share	853.83	844.14	763.05	731.55	619.82	674.08
Tangible Book Value	79,795	82,613	58,931	56,247	26,902	25,638
Tangible Book Value Per Share	772.77	800.06	747.10	713.06	584.16	638.08
Land	-	24,613	22,718	21,203	10,460	10,460
Buildings	-	4,924	4,795	4,795	4,809	4,809
Machinery	-	17,814	15,946	14,864	14,680	13,223
Construction In Progress	-	79.71	50	227.5	115.81	16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.